TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Stock Market Lead
Play
JIM CRAMER

Whole New Game: Cramer's 'Mad Money' Recap (Tuesday 6/23/20)

  • By Scott Rutt
  • Jun 23, 2020 8:58 PM EDT
PRESS RELEASES

Agenus Enters Into Clinical Collaboration With Nelum For Zalifrelimab Combination

  • By GlobeNewswire
  • Jan 26, 2021 8:30 AM EST
PRESS RELEASES

Agenus To Participate In B. Riley Securities' Oncology Investor Conference

  • By GlobeNewswire
  • Jan 19, 2021 12:09 PM EST
PRESS RELEASES

Completion Of Balstilimab BLA Filing Extended To 1H2021

  • By GlobeNewswire
  • Dec 3, 2020 7:45 AM EST
PRESS RELEASES

Agenus Launches Phase 2 Trial Expansion In Colon Cancer For AGEN1181 In Combination With Balstilimab

  • By GlobeNewswire
  • Dec 1, 2020 8:00 AM EST
PRESS RELEASES

Agenus To Participate In Evercore ISI 3rd Annual HealthCONx Conference

  • By GlobeNewswire
  • Nov 25, 2020 1:28 PM EST
PRESS RELEASES

VBI Vaccines Announces Positive Interim Phase 2a Data From VBI-1901 In Recurrent GBM

  • By Business Wire
  • Nov 19, 2020 8:00 AM EST
PRESS RELEASES

Agenus To Participate In Fireside Chat At The Jefferies 2020 Virtual London Healthcare Conference

  • By GlobeNewswire
  • Nov 16, 2020 7:04 PM EST
PRESS RELEASES

Agenus And Dr. Steven O'Day To Participate In Webcast Hosted By William Blair On AGEN1181 And SITC Data

  • By GlobeNewswire
  • Nov 13, 2020 2:42 PM EST
PRESS RELEASES

Agenus And Dr. Steven O'Day To Participate In Panels At The Virtual SITC 2020 Immuno-Oncology Event Hosted By B. Riley

  • By GlobeNewswire
  • Nov 12, 2020 9:00 AM EST
PRESS RELEASES

An Agenus-discovered First-in-class ILT4 Antibody, MK-4830, Enters Phase 2

  • By GlobeNewswire
  • Nov 10, 2020 8:45 AM EST
PRESS RELEASES

Dr. Steven O'Day Named Agenus Chief Medical Officer

  • By GlobeNewswire
  • Nov 5, 2020 8:00 AM EST
PRESS RELEASES

Agenus Doses First COVID-19 Patient With INKT Cell Therapy

  • By GlobeNewswire
  • Nov 2, 2020 8:45 AM EST
PRESS RELEASES

Agenus To Report Third Quarter Earnings

  • By GlobeNewswire
  • Oct 20, 2020 10:34 AM EDT
PRESS RELEASES

Agenus To Present On Seven Novel Programs At SITC 2020

  • By GlobeNewswire
  • Oct 14, 2020 5:00 PM EDT
PRESS RELEASES

Agenus Initiates Rolling BLA Submission Of Balstilimab For Recurrent/Metastatic Cervical Cancer

  • By GlobeNewswire
  • Sep 18, 2020 8:30 AM EDT
PRESS RELEASES

Dr. Jennifer Buell Speaks Live At Scientific American Inaugural Fireside Chat Series 18 Minutes With

  • By GlobeNewswire
  • Sep 17, 2020 5:06 PM EDT
PRESS RELEASES

Agenus To Participate In Webcast Hosted By William Blair On ESMO2020 Results And Novel Pipeline

  • By GlobeNewswire
  • Sep 17, 2020 1:38 PM EDT
PRESS RELEASES

Paul Clark Joins Agenus Board Of Directors

  • By PR Newswire
  • Aug 31, 2020 8:00 AM EDT
PRESS RELEASES

Agenus Announces ESMO Oral Presentation Of Two Clinical Trials Of Balstilimab Alone And In Combination With Zalifrelimab In Recurrent Or Metastatic Cervical Cancer

  • By PR Newswire
  • Aug 26, 2020 2:46 PM EDT
PRESS RELEASES

Agenus To Present On Targeting Myeloid Cells In Tumor Microenvironment At The William Blair Biotech Focus 2020 Conference

  • By PR Newswire
  • Aug 4, 2020 8:30 AM EDT
PRESS RELEASES

Agenus Receives $35M In Immuno-Oncology Transaction With Betta Pharmaceuticals

  • By PR Newswire
  • Jul 28, 2020 11:23 AM EDT
PRESS RELEASES

Agenus To Participate In A Panel On Cell Therapy For Infectious Diseases At The B. Riley Virtual Infectious Disease Summit

  • By PR Newswire
  • Jul 21, 2020 1:31 PM EDT
Stock Market Lead
JIM CRAMER

Whole New Game: Cramer's 'Mad Money' Recap (Tuesday 6/23/20)

  • By Scott Rutt
  • Jun 23, 2020 8:58 PM EDT
PRESS RELEASES

Agenus Cell Therapy And Checkpoint Antibody Combinations Show Curative Preclinical Efficacy At AACR 2020

  • By PR Newswire
  • Jun 22, 2020 9:43 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.